CTRI/2024/05/067542尚未招募4 期
Efficacy and Safety of Fluvoxamine alone and in combination with L-Methyltetrafolate in patients with Obsessive Compulsive Disorder - nil
PT B.D Sharma UHS Rohtak0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1)Age 18-65 years
- •2)Patient fulfilling the criteria of OCD as
- •per ICD-11 any severity YBOCS score more than
- •3) Willing to participate and give
- •informed consent
排除标准
- •1) Current diagnosis of OCD with
- •psychotic features or any other
- •psychiatric diagnosis in the past
- •2) Patient with a history of any
- •chronic physical illness
- •3) Current psychoactive substance use
- •Pregnant and lactating women
研究者
相似试验
尚未招募
不适用
Comparison of Drugs, Fluvoxamine and Fluoxetine in patients with OCD in terms of efficacy and effect on clinical and biochemical parameters.CTRI/2023/01/048722Government Medical College and Hospital, Chandigarh
招募中
4 期
A longitudinal study of the fluvoxamine treatment for the structural and functional connectivity between the orbitofrontal cortex and the ventral striatum in obsessive compulsive disorderobsessive-compulsive disorderJPRN-jRCT1051180029akamae takashi30
招募中
不适用
A longitudinal study of the fluvoxamine treatment for the structural and functional connectivity between the orbitofrontal cortex and the ventral striatum in obsessive compulsive disorderobsessive-compulsive disorderJPRN-UMIN000022815Department of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine,30
已完成
3 期
Fluvoxamine in Long COVIDong or Post COVID syndrome.Post COVID-19 condition occurs in individuals with a history of probable or confirmed SARS CoV-2 infection, usually 3 months from the onset of COVID-19 with symptoms and that last for at least 2 months and cannot be explained by an alternative diagnosis.U09.9IRCT20220526054990N1Artesh University of Medical Sciences96
进行中（未招募）
不适用
The effect of fluvoxamine and ciprofloxacin on the pharmacokinetics and pharmacodynamics of nabumetone: A three-phase double-blind placebo-controlled cross-over study.Pharmacokinetics and pharmacodynamics, healthy volunteer trialEUCTR2008-007647-14-FITurku University Hospital12